Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis egestas nec ligula in viverra. Donec quis risus ex. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Vivamus dictum neque nec lacus ultricies facilisis. Quisque dapibus vehicula volutpat. Donec justo enim, pretium sed tristique eget, porta id enim. Sed posuere, orci varius sagittis vehicula, diam lorem pellentesque velit, eget interdum orci sapien quis nibh. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Fusce nec risus vulputate, fermentum turpis vitae, congue arcu. Ut tempor, erat non pellentesque ullamcorper, turpis orci mattis ante, nec aliquam nisl leo eget nulla. In hac habitasse platea dictumst. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae;

Etiam a velit tempus, bibendum magna a, semper quam. Morbi non lectus nulla. Cras ac leo vitae ex vulputate porttitor non ac risus. Quisque efficitur eleifend sem, ac dapibus urna sollicitudin eu. Fusce augue quam, molestie id mattis nec, porta at nisl. Pellentesque vitae aliquet tellus. Aenean sed quam metus. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Mauris libero nunc, vulputate vel sollicitudin eu, varius volutpat diam. Sed ultricies ligula quis aliquet tempus. Etiam id enim a diam luctus aliquet. Maecenas malesuada vitae neque eget efficitur. Maecenas tincidunt vitae arcu ut dictum. Maecenas pulvinar orci sed consectetur dictum.

Cras sit amet bibendum justo, sed imperdiet urna. Suspendisse pellentesque turpis augue. Maecenas quis est egestas, cursus dui ut, tristique lectus. Aliquam at mollis lorem. Phasellus in ultrices arcu. Cras tincidunt orci mauris, sit amet gravida dui vestibulum vitae. Pellentesque vitae dolor dictum, sagittis sapien a, auctor libero.

Ut id justo sit amet nulla sodales tristique. Nunc sollicitudin lectus vitae mauris interdum, scelerisque dapibus ante efficitur. Praesent varius eu dui vitae blandit. Mauris laoreet posuere accumsan. Etiam eget diam et est gravida ornare. Duis suscipit mattis hendrerit. Phasellus nisi arcu, fringilla eget vestibulum nec, maximus non arcu. Nullam aliquet dapibus sem, nec pretium nisi vehicula sit amet.

Quisque id placerat ante. Sed at orci a purus vestibulum laoreet. In accumsan risus nisi. Vestibulum et consequat turpis, id venenatis nibh. Suspendisse leo felis, volutpat sit amet eros nec, auctor ultrices dui. Morbi aliquet finibus odio id tempus. Etiam quis sagittis quam. Integer dapibus ex id mi dapibus luctus.

  MARKET NEWS

BioCanCell Announces Completion of $23-Million Financing
Immutep Submits IND Application With FDA
Conatus Pharmaceuticals’ Pan-Caspase Inhibitor Emricasan Improves Survival & Portal Hypertension
Catalent Signs Agreement to Acquire Juniper Pharmaceuticals
BASi & Seventh Wave Laboratories Combine Operations to Provide Broader Solutions & Greater Scientific Expertise to Clients
ASLAN Pharmaceuticals Submits Clinical Trial Authorization Application

  FEATURED EDITORIAL

  COMPANY PROFILE

LATITUDE Pharmaceuticals Inc. is a leading-edge research boutique that provides innovative drug formulation development services to the human and animal health biotech/pharmaceutical industries. Since our founding in 2003, we have completed more than 750 client projects and established a reputation for successfully formulating highly insoluble compounds – a problem attributable to 40% of new drug development failures. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Biologic Excipients Market Expected to be Valued at .7 Billion by End of 2028

Biologic Excipients Market Expected to be Valued at $1.7 Billion by End of 2028

Future Market Insights (FMI) delivers key insights on the global biologic excipients market in its upcoming report titled Biologic Excipients Market: Global Industry Analysis 2013–2017 and Opportunity Assessment…

Lonza Pharma & Biotech

Lonza Launches New Bioscience Website

Lonza Bioscience is inviting visitors to explore its new dedicated website: bioscience.lonza.com.

Evonik Expands North American Contract Development & Manufacturing Capabilities for Advanced Injectables

Evonik Expands North American Contract Development & Manufacturing Capabilities for Advanced Injectables

Evonik recently announced a €35 million expansion of its contract development and manufacturing (CDMO) capabilities in North America to meet growing demand for controlled release injectable formulations. The expansion of the U.S. and Canadian facilities, which includes the installation of a new filling line, production facilities and analytical labs, will create more than 50 jobs.

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

Upcoming eNewsletter Features:
AUG 15 Analytical Testing
AUG 22 ODT/Fast Dissolve
AUG 29 Transdermal/Topical Delivery
SEPT 5 Drug Delivery